Dr David MacDougall

Consultant Cardiologist

BSc (Hons), MB ChB, MRCP

Professional Memberships

  • Royal College of Physicians of Edinburgh
  • British Cardiovascular Society
  • Heart Failure Association of the European Society of Cardiology

Clinical Interests

  • Chest pain and coronary artery disease
  • Coronary angiography and angioplasty
  • Hyperlipidaemia and hypercholestrolaemia
  • Palpitations and arrhythmia 
  • Atrial fibrillation
  • Valvular heart disease
  • Hypertension

Specialises in percutaneous coronary intervention.

Personal profile

Dr David MacDougall is a Consultant Cardiologist, specialising in Interventional Cardiology at University Hospital Hairmyres (UHH). Together with the Golden Jubilee Hospital, UHH provides an Optimal Reperfusion Service for heart attack patients in the West of Scotland. UHH is currently the busiest centre in Scotland that provides this service, which is also known as Primary Percutaneous Coronary Intervention (PPCI).

He graduated from the University of Edinburgh in 1991 with MBChB and an Honours Degree in Biochemistry. He completed seven years of cardiology training at world renowned Papworth Hospital, Cambridge which is the biggest cardiothoracic transplant centre in the UK. During his training in Interventional Cardiology, he undertook a Fellowship at one of Europe’s most prestigious cardiac centres, the Herzzentrum (Heart Centre) in Leipzig, Germany.

He was appointed as Consultant Cardiologist in Hairmyres Hospital in 2007. He teaches coronary intervention to trainees who rotate from the West of Scotland and to European interventional fellows.

In addition to cardiology subspecialties, Dr MacDougall has an interest in lipidology, for which he is the Lead Clinician in South Lanarkshire. His service offers genetic testing for Familial Hypercholesterolaemia, a condition that can result in premature coronary artery disease, heart attacks and reduced life expectancy. As part of a preventive cardiology strategy, he also advises regarding lifestyle changes to improve patients’ cholesterol profiles with or without the need for pharmacotherapy.

Year qualified:

1991